The understated green and white box labeled Aspirina that started rolling out in select Walmart and Walgreens locations this ...

The drug can be produced for as little as $25 per person annually, but even at $2000 per person, it can reduce new US infections almost entirely, a researcher says.

From discontinued insulin pens to overpriced TB drugs, meet the young South African holding drug makers to account on behalf ...

There was no significant difference in virologic efficacy through 96 weeks in adults with HIV who switched to DTG/3TC vs ...

Among patients with late diagnosed HIV infection, the choice of a two- or three-drug regimen is not associated with 48 week ...

The American South has the highest HIV rates in the country, accounting for more than half of new HIV diagnoses nationwide in ...

By Dickens Okinyi Kenya’s ongoing fight against HIV has entered a new phase with the roll out of Lenacapavir, a groundbreaking long-acting HIV prevention and treatment drug, set to take place in 2026.

The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...

NEIGHBOURS of Scotland’s first heroin ‘fix room’ are risking HIV and hepatitis by clearing up syringes dumped in their ...

Lesotho reached a milestone late last year — UNAIDS’s 95-95-95 goal, with 95% of people living with HIV aware of their status ...

In the wake of massive U.S. cuts to foreign aid, the tiny country of Lesotho in southern Africa faces deep uncertainty and ...